Psychological symptom patterns and vital exhaustion in outpatients with chronic obstructive pulmonary disease.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3253052)

Published in Ann Gen Psychiatry on December 06, 2011

Authors

Athanasios Tselebis1, Dionisios Bratis, Epaminondas Kosmas, Maria Harikiopoulou, Elpida Theodorakopoulou, Silvia Dumitru, Georgios Moussas, Athanasios Karkanias, Ioannis Ilias, Nikolaos Siafakas, Alexandros Vgontzas, Nikolaos Tzanakis

Author Affiliations

1: Psychiatric Department, Sotiria General Hospital of Chest Diseases, Athens, Greece. atselebis@yahoo.gr.

Articles cited by this

A power primer. Psychol Bull (1992) 63.66

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86

Earlier diagnosis and earlier treatment of COPD in primary care. Prim Care Respir J (2011) 2.95

Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest (2008) 2.37

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax (2010) 2.26

Mental precursors of myocardial infarction. Br J Psychiatry (1990) 1.73

Prevalence of COPD in Greece. Chest (2004) 1.69

Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics (2001) 1.66

Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest (1985) 1.60

Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry (2000) 1.55

A questionnaire to assess premonitory symptoms of myocardial infarction. Int J Cardiol (1987) 1.55

Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract (2007) 1.48

Depressive symptomatology and vital exhaustion are differentially related to behavioral risk factors for coronary artery disease. Psychosom Med (1999) 1.32

Depressive symptoms as predictors of mortality in patients with COPD. Chest (2008) 1.25

The association between depressive symptoms and health status in patients with chronic pulmonary disease. Gen Hosp Psychiatry (2001) 1.20

Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest (2006) 1.16

A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases. Ann Gen Psychiatry (2008) 1.16

Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis (2008) 1.05

The relationship between vital exhaustion, depression and comorbid illnesses in patients following first myocardial infarction. J Psychosom Res (2004) 1.04

Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation. J Cardiopulm Rehabil (2000) 1.00

Vital exhaustion as risk indicator for myocardial infarction in women. J Psychosom Res (1993) 0.97

Vital exhaustion and depression: a conceptual study. J Psychosom Res (1991) 0.94

Global assessment of the COPD patient: time to look beyond FEV1? Respir Med (2009) 0.93

Anxiety and depression in Greek nursing and medical personnel. Psychol Rep (2006) 0.86

Fatigue in patients with COPD participating in a pulmonary rehabilitation program. Int J Chron Obstruct Pulmon Dis (2010) 0.86

Multidimensional analysis of the symptoms of chronic bronchitis and emphysema. J Behav Med (1983) 0.84

Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients. Ann Gen Psychiatry (2010) 0.82

Characteristics of patients with chronic obstructive pulmonary disease choosing rehabilitation. J Rehabil Med (2010) 0.82

Coexistent chronic obstructive pulmonary disease-heart failure: mechanisms, diagnostic and therapeutic dilemmas. Indian J Chest Dis Allied Sci (2011) 0.81

Psychological prodromata of myocardial infarction and sudden death. Psychother Psychosom (1980) 0.79

Articles by these authors

Cognitive impairment is related to increased arterial stiffness and microvascular damage in patients with never-treated essential hypertension. Am J Hypertens (2009) 2.24

Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med (2004) 2.14

The diagnosis and management of malignant phaeochromocytoma and paraganglioma. Endocr Relat Cancer (2007) 2.10

Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J (2011) 2.08

Protective effect of fruits, vegetables and the Mediterranean diet on asthma and allergies among children in Crete. Thorax (2007) 1.98

Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci (2003) 1.84

Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab (2005) 1.77

Prevalence of COPD in Greece. Chest (2004) 1.69

Smoking related to anxiety and depression in Greek medical staff. Psychol Rep (2003) 1.63

Allergic rhinitis, asthma, and atopy among grape farmers in a rural population in Crete, Greece. Chest (2005) 1.56

Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med (2012) 1.52

Induced sputum versus bronchoalveolar lavage fluid in the evaluation of patients with idiopathic pulmonary fibrosis. Respiration (2005) 1.44

Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases. Ann N Y Acad Sci (2002) 1.42

Vascular-specific growth factor mRNA levels in the human diaphragm. Respiration (2005) 1.42

Perforin expression and cytotoxic activity of sputum CD8+ lymphocytes in patients with COPD. Chest (2004) 1.39

The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome. J Clin Endocrinol Metab (2004) 1.36

Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma (2002) 1.31

Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28

Evaluation and treatment of Cushing's syndrome. Am J Med (2005) 1.19

The role of diet and lifestyle in primary, secondary, and tertiary diabetes prevention: a review of meta-analyses. Rev Diabet Stud (2010) 1.19

A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases. Ann Gen Psychiatry (2008) 1.16

Plasma pro- and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine (2008) 1.16

Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med (2006) 1.15

Current trends in functional imaging of pheochromocytomas and paragangliomas. Ann N Y Acad Sci (2006) 1.15

Sleep disordered breathing in patients with acute coronary syndromes. J Clin Sleep Med (2012) 1.14

Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients. Tuberc Res Treat (2013) 1.10

Isolation of myeloid and plasmacytoid dendritic cells from human bronchoalveolar lavage fluid. Immunol Cell Biol (2006) 1.10

Survivin -31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis (2008) 1.07

Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med (2005) 1.06

Evaluation of seroneutralization and molecular diagnostic methods for echovirus identification. Diagn Microbiol Infect Dis (2005) 1.04

Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03

Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome. Hormones (Athens) (2009) 1.02

Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis. Chest (2006) 1.02

Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Shock (2009) 1.02

Respiratory kinematics by optoelectronic plethysmography during exercise in men and women. Eur J Appl Physiol (2004) 1.00

Perchlorate and thiocyanate exposure and thyroid function in first-trimester pregnant women from Greece. Clin Endocrinol (Oxf) (2012) 0.99

Cytokines and pathological sleep. Sleep Med (2007) 0.98

CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep? Sleep Breath (2013) 0.98

Interleukin-6: a cytokine and/or a major modulator of the response to somatic stress. Ann N Y Acad Sci (2006) 0.98

Prognostic value of serum tumor markers in patients with lung cancer. Respiration (2002) 0.96

Predicting ICU survival: a meta-level approach. BMC Health Serv Res (2008) 0.95

Is there any correlation between the ATS, BTS, ERS and GOLD COPD's severity scales and the frequency of hospital admissions? Respir Med (2004) 0.94

Association of target organ damage with three arterial stiffness indexes according to blood pressure dipping status in untreated hypertensive patients. Am J Hypertens (2010) 0.94

Nitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPD. Chest (2005) 0.93

Expression of nuclear factor kappaB in human gastric carcinoma: relationship with I kappaB a and prognostic significance. Virchows Arch (2007) 0.93

Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites. Nucl Med Commun (2006) 0.93

Decreased small airway and alveolar CD83+ dendritic cells in COPD. Chest (2009) 0.93

Association of perceived family support through glycemic control in native Greek patients managing diabetes with diet alone. Ethn Dis (2004) 0.93

Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res (2006) 0.92

Association of allergic rhinitis with pesticide use among grape farmers in Crete, Greece. Occup Environ Med (2006) 0.92

Alexithymia and its association with burnout, depression and family support among Greek nursing staff. Hum Resour Health (2009) 0.90

The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma. Cytokine (2013) 0.90

Comorbidities and chronic obstructive pulmonary disease: is there a place for lung fibrosis? Am J Respir Crit Care Med (2013) 0.90

Changes in sputum T-lymphocyte subpopulations at the onset of severe exacerbations of chronic obstructive pulmonary disease. Respir Med (2004) 0.90

Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep (2013) 0.90

CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role? Sleep Breath (2011) 0.89

Decreased sputum mature dendritic cells in healthy smokers and patients with chronic obstructive pulmonary disease. Int Arch Allergy Immunol (2009) 0.89

Angiogenic molecule Tie-2 and VEGF in the pathogenesis of pleural effusions. Respir Med (2008) 0.88

C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy. Eur J Clin Invest (2010) 0.88

Associations on dimensions of burnout and family support for a sample of Greek nurses. Psychol Rep (2008) 0.88

Different angiogenic CXC chemokine levels in bronchoalveolar lavage fluid after interferon gamma-1b therapy in idiopathic pulmonary fibrosis patients. Pulm Pharmacol Ther (2008) 0.87

Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study. Can Respir J (2002) 0.87

Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis. Int J Antimicrob Agents (2008) 0.87

The expression of matrix metalloproteinases-2 and -9 and their tissue inhibitor 2 in pancreatic ductal and ampullary carcinoma and their relation to angiogenesis and clinicopathological parameters. Anticancer Res (2008) 0.87

Altered surfactant protein-A expression in type II pneumocytes in COPD. Chest (2009) 0.87

Anxiety and depression in Greek nursing and medical personnel. Psychol Rep (2006) 0.86

Fatigue, endocrinopathies, and metabolic disorders. PM R (2010) 0.86

Downregulation of lung mitochondrial prohibitin in COPD. Respir Med (2012) 0.86

Effects of antifibrotic agents on TGF-beta1, CTGF and IFN-gamma expression in patients with idiopathic pulmonary fibrosis. Respir Med (2007) 0.86

Managing comorbidity in COPD: a difficult task. Curr Drug Targets (2013) 0.85

Effects of exercise-induced arterial hypoxaemia and work rate on diaphragmatic fatigue in highly trained endurance athletes. J Physiol (2006) 0.85

Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma. Pancreas (2007) 0.85

New therapeutic options for the metabolic syndrome: what's next? Trends Endocrinol Metab (2005) 0.85

Molecular pathways and genetic factors in the pathogenesis of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol (2009) 0.84

Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest (2002) 0.84

Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis. BMC Pulm Med (2005) 0.84

fbl gene as a species-specific target for Staphylococcus lugdunensis identification. J Clin Lab Anal (2010) 0.84

Sputum and nasal lavage lung-specific biomarkers before and after smoking cessation. BMC Pulm Med (2011) 0.84

Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis. Sleep Breath (2014) 0.84

Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility. Curr Med Res Opin (2004) 0.83

Identification of staphylococci by Phoenix: validation of a new protocol and comparison with Vitek 2. Diagn Microbiol Infect Dis (2010) 0.83

Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer. Gastric Cancer (2011) 0.83

Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects. Neuroimmunomodulation (2005) 0.83

Serum tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2) levels in colorectal cancer patients: associations with clinicopathological variables and patient survival. Int J Biol Markers (2010) 0.83

Hypothalamic-pituitary-adrenal axis and interleukin-6 activity in children with head trauma and syndrome of inappropriate secretion of antidiuretic hormone. J Pediatr Endocrinol Metab (2003) 0.82

Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients. Ann Gen Psychiatry (2010) 0.82

Quality of life in patients with active sarcoidosis in Greece. Eur J Intern Med (2006) 0.82